​

Funding Round

Series B - Insitro

Series B - Insitro

Investment Firm

Overview

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Announced Date

May 26, 2020

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

13

Investor Name
Participant InvestorGoogle Ventures
Participant InvestorCanada Pension Plan Investment Board
Participant InvestorARCH Venture Partners
Participant InvestorThird Rock Ventures
Participant InvestorBlackRock

Round Details and Background

Insitro raised $143000000 on 2020-05-26 in Series B

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 02, 2018
Series A - Insitro
10-100.0M
May 26, 2020
Series B - Insitro
14-143.0M
Mar 15, 2021
Series C - Insitro
14-400.0M

Recent Activity

There is no recent news or activity for this profile.